Why is eosinophils low

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Low eosinophils (eosinopenia) typically occur when eosinophil counts fall below 50 cells per microliter of blood, with normal ranges being 50-500 cells/μL. Common causes include acute stress from infections like sepsis, use of corticosteroids, or Cushing's syndrome, which suppress eosinophil production. This condition is often temporary and resolves when the underlying trigger is addressed, but persistent low levels may indicate immune system issues.

Key Facts

Normal eosinophil range is 50-500 cells per microliter of blood
Eosinopenia is defined as eosinophil counts below 50 cells/μL
Corticosteroid use can reduce eosinophil counts by 50-90% within hours
Acute bacterial infections like sepsis commonly cause eosinopenia
Cushing's syndrome suppresses eosinophil production through cortisol excess

Overview

Eosinophils are a type of white blood cell that play crucial roles in immune responses, particularly against parasitic infections and in allergic reactions. First identified by Paul Ehrlich in 1879 through his staining techniques, eosinophils derive their name from their affinity for eosin dye, appearing pink under microscopy. These cells typically constitute 1-6% of circulating white blood cells in healthy individuals, with normal absolute counts ranging from 50 to 500 cells per microliter of blood. Historically, eosinophils were primarily associated with parasitic defense, but research since the 1980s has revealed their involvement in asthma, eczema, and other inflammatory conditions. The discovery of eosinophil-derived neurotoxin in 1985 further expanded understanding of their functions. In clinical practice, eosinophil counts are routinely measured through complete blood count (CBC) tests, with results helping diagnose various conditions from allergies to autoimmune disorders.

How It Works

Eosinopenia occurs through several physiological mechanisms that suppress eosinophil production or increase their destruction. Acute stress responses, particularly from infections like sepsis or trauma, trigger cortisol release which inhibits eosinophil production in bone marrow—this can reduce counts by 50-90% within hours. Corticosteroid medications mimic this effect by binding to glucocorticoid receptors, suppressing interleukin-5 (IL-5) production that normally stimulates eosinophil growth. In Cushing's syndrome, chronic cortisol excess similarly dampens eosinophil development. Additionally, certain chemotherapy drugs directly target rapidly dividing cells including eosinophil precursors. The process begins when stress signals activate the hypothalamic-pituitary-adrenal axis, leading to cortisol secretion that alters gene expression in hematopoietic stem cells, reducing eosinophil differentiation. Meanwhile, existing eosinophils may undergo apoptosis or migrate to tissues, further decreasing circulating numbers.

Why It Matters

Monitoring eosinophil levels has significant clinical importance because persistent eosinopenia can indicate serious underlying conditions. In emergency medicine, rapidly declining eosinophil counts often signal developing sepsis, helping guide antibiotic therapy decisions. For patients on long-term corticosteroids, tracking eosinophils helps assess medication effects and adjust dosages to minimize side effects. In endocrinology, unexplained eosinopenia may prompt testing for Cushing's syndrome. Furthermore, research suggests eosinophil fluctuations correlate with COVID-19 severity, with lower counts associated with worse outcomes. Beyond healthcare, understanding eosinophil biology aids pharmaceutical development, such as creating targeted therapies for eosinophilic disorders while avoiding excessive suppression.